发明申请
US20080081812A1 Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
有权
杂芳基吡唑衍生物作为大麻素CB1受体拮抗剂
- 专利标题： Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
- 专利标题（中）： 杂芳基吡唑衍生物作为大麻素CB1受体拮抗剂
-
申请号： US11863501申请日： 2007-09-28
-
公开(公告)号： US20080081812A1公开(公告)日： 2008-04-03
- 发明人: Jinhwa LEE , Jeong Kim , Chong-Hwan Chang , Suk Lee , Hee Seo , Suk Kang , Kwang-Seop Song , Jong Kim , Min-ah Kim , Sung-han Lee , Kwang-Woo Ahn , Myung Eun Jung , Ji-Hyun Park
- 申请人： Jinhwa LEE , Jeong Kim , Chong-Hwan Chang , Suk Lee , Hee Seo , Suk Kang , Kwang-Seop Song , Jong Kim , Min-ah Kim , Sung-han Lee , Kwang-Woo Ahn , Myung Eun Jung , Ji-Hyun Park
- 申请人地址： KR Yongin-si 446-770
- 专利权人： Green Cross Corporation
- 当前专利权人： Green Cross Corporation
- 当前专利权人地址： KR Yongin-si 446-770
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/41 ; A61K31/4196 ; A61K31/4245 ; A61K31/433 ; C07D213/02 ; C07D241/10 ; C07D257/04 ; C07D271/10 ; C07D295/00 ; C07D285/12 ; C07D271/06 ; C07D249/08 ; C07D221/00 ; A61P3/04 ; A61K31/4427 ; A61K31/4523 ; A61K31/497
摘要：
A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
公开/授权文献
信息查询
IPC分类:
